Acacia Fiber (Gum Arabic)
A nearly tasteless, non-viscous soluble fiber that is slowly and completely fermented, feeding bifidobacteria with minimal gas.
What is Acacia Fiber (Gum Arabic)?
Acacia Fiber (Gum Arabic) (Acacia senegal) is a prebiotic fiber used for bifidogenic prebiotic: selectively increases bifidobacterium and lactobacillus and raises colonic short-chain fatty acids (acetate/propionate), with much lower gas and bloating than inulin or fos because it ferments slowly and completely. NutriDex grades the human evidence as Moderate. Acacia fiber (gum arabic), the dried exudate of Acacia senegal/seyal trees, is a highly branched arabinogalactan-protein soluble fiber that is non-viscous and slowly, near-completely fermented in the colon to short-chain fatty acids. Its best-documented effect is bifidogenic: human studies show selective increases in Bifidobacterium and Lactobacillus at roughly 10 g/day, with notably low gas and bloating versus inulin/FOS because fermentation is gradual. Randomized trials, mostly small and many from Sudan, also report modest reductions in BMI and body fat in women (30 g/day) and improvements in glycemia, lipids and blood pressure in type 2 diabetes and metabolic syndrome, plus anti-inflammatory (lower CRP) effects in CKD; however these cardiometabolic trials are small, single-region and not yet confirmed by large independent RCTs, so that evidence is preliminary-to-moderate. A 2024 RCT in IBS-C found 10 g/day increased stool frequency above the FDA clinical-relevance threshold.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Bifidogenic prebiotic with low gas/bloatingDose-response human study shows ~10 g/day selectively raises Bifidobacterium/Lactobacillus with better tolerance than inulin. | Moderate | ↑ benefit · moderate | 2 |
| Improves bowel regularity (IBS-C)One 2024 RCT (n=180) at 10 g/day raised weekly stool frequency above FDA relevance threshold; single trial. | Preliminary | ↑ benefit · moderate | 1 |
| Reduces body weight / adipositySmall single-region RCTs (Sudan) at 30 g/day cut BMI/body fat; not confirmed by large independent trials. | Preliminary | ↑ benefit · moderate | 2 |
| Improves glycemic control (fasting glucose, HbA1c)One T2D RCT showed lower FPG/HbA1c, but a 2025 meta-analysis judged acacia evidence limited and inconsistent. | Mixed | ↔ mixed | 2 |
| Lowers blood pressure & lipidsSmall metabolic-syndrome/T2D RCTs report modest BP and lipid drops; smaller, less consistent than psyllium/oat. | Preliminary | ↑ benefit · small | 2 |
| Lowers inflammation (CRP) in kidney diseaseCKD RCT lowered CRP but did not change urea/creatinine/indoxyl sulfate; single condition-specific trial. | Preliminary | ↑ benefit · moderate | 1 |